Hemoglobin Oxygen Therapeutics LLC (HOTI)
Hemoglobin Oxygen Therapeutics LLC will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

HOTI Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec '21 Dec '20
Net Income
-6.13-6.13-3.59
Depreciation & Amortization
0.60.60.55
Other Operating Activities
3.613.612.11
Operating Cash Flow
-1.91-1.91-0.93
Capital Expenditures
---0.05
Investing Cash Flow
---0.05
Debt Issued / Paid
221.26
Financing Cash Flow
221.26
Net Cash Flow
0.090.090.28
Free Cash Flow
-1.91-1.91-0.98
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).